Recombinant Human VEGF165 Protein，His

Vascular endothelial growth factor (VEGF) is a key signaling protein that primarily regulates angiogenesis, the formation of new blood vessels from pre-existing ones. Among its isoforms, VEGF165 is the most abundant and biologically active variant, playing a critical role in both normal physiological processes and various pathological conditions, such as cancer, diabetes, and eye diseases like age-related macular degeneration. The study of VEGF165 recombinant protein has gained significant attention due to its potential applications in therapeutic interventions and regenerative medicine. Understanding the structure and function of VEGF165 can facilitate the development of VEGF inhibitors for anti-cancer strategies or VEGF-based therapies to promote tissue regeneration and repair. Moreover, investigations into VEGF165's interactions with its receptors offer insights into the underlying molecular mechanisms of angiogenesis and vascular permeability. The recombinant production of VEGF165 allows for the exploration of its effects in controlled experimental settings, paving the way for innovative treatment modalities targeting VEGF-mediated pathways. As such, ongoing research into VEGF165 holds promise for advancing our knowledge of vascular biology and enhancing therapeutic options for diseases characterized by abnormal angiogenesis.